Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Asset Utilization Ratio (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.7 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 3.74% year-over-year to 0.7, compared with a TTM value of 0.7 through Dec 2025, up 3.74%, and an annual FY2025 reading of 0.73, up 8.15% over the prior year.
  • Asset Utilization Ratio was 0.7 for Q4 2025 at Amicus Therapeutics, down from 0.71 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.71 in Q2 2025 and bottomed at 0.31 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.51, with a median of 0.49 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio skyrocketed 35.23% in 2022, then rose 3.74% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.33 in 2021, then skyrocketed by 35.23% to 0.44 in 2022, then increased by 16.72% to 0.52 in 2023, then grew by 29.79% to 0.67 in 2024, then grew by 3.74% to 0.7 in 2025.
  • Business Quant data shows Asset Utilization Ratio for FOLD at 0.7 in Q4 2025, 0.71 in Q3 2025, and 0.71 in Q2 2025.